XXP-10024-74415 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2021-01-07
Registered in v-safe
2021-01-07
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-08
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-08
Report sent to call center — day 0, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Cough, Decreased appetite, Pain of skin, Sensitive skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Cough, Loss of appetite, sensitive skin/skin painful to touch

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-01-12
Survey response — days 1–6 daily, dose 2
MedDRA: Cough — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-16
Call 1 — Left Voicemail
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-08
Survey response — 12 months, dose 2
MedDRA: Peripartum cardiomyopathy, Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization

Free text: Pregnancy and peripartum cardiomyopathy

MedDRA releases: 2024-11 · check-in free text available
2022-01-08
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
2022-01-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-08	Unsuccessful
2021-01-09	Unsuccessful
2022-01-08	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Cough, Loss of appetite, sensitive skin/skin painful to touch

2021-01-12

Systemic reaction (other): Cough

Release 10 — 12 months, dose 2

2022-01-08

Symptoms: Pregnancy and peripartum cardiomyopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Peripartum cardiomyopathy	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Cough	✓	✓	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Pain of skin	✓	✓	✓
SRO	Sensitive skin	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release